Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of antimicrobial chemotherapy 2010-09, Vol.65 (9), p.2050-2052
Hauptverfasser:	Pinnetti, Carmela, Baroncelli, Silvia, Villani, Paola, Fantoni, Massimo, Tozzi, Valerio, De Luca, Andrea, Cauda, Roberto, Anzidei, Gianfranco, Cusato, Maria, Regazzi, Mario, Floridia, Marco, Tamburrini, Enrica
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenine - administration & dosage Adenine - analogs & derivatives Anti-HIV Agents - administration & dosage Antibiotics. Antiinfectious agents. Antiparasitic agents Antiretroviral Therapy, Highly Active - methods Biological and medical sciences drug plasma levels Female HAART HIV Infections - drug therapy HIV Infections - virology Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Medical sciences mother to child transmission Organophosphonates - administration & dosage Pharmacology. Drug treatments Pregnancy Pregnancy Complications, Infectious - drug therapy Pregnancy Complications, Infectious - virology Pyrrolidinones - administration & dosage Raltegravir Potassium RNA, Viral - blood Tenofovir Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral Load Viremia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!